A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay
- PMID: 27515178
- PMCID: PMC4982146
- DOI: 10.1186/s40880-016-0142-y
A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer death worldwide and is characterized by numerous genetic mutations. TNM staging is not sufficient for predicting patient outcomes. Additionally, ESCC shows poor responsiveness to chemotherapy and radiation. Thus, there is an urgent need to find efficient therapy targets. Previous ESCC high-throughput genomic studies have lacked intensive survival analysis, particularly for copy number variation (CNV) and the genes involved.
Main body: In the study "Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor Prognosis" recently published in the American Journal of Human Genetics, we comprehensively analyzed the effects of CNVs, mutations, and relative gene expression on patient outcomes. To validate our findings for our 67 sequencing samples, we collected a 321-patient retrospective cohort with detailed 5-year follow-up information and carried out univariate and multivariate survival analyses. In addition, the biological functions of the survival predictors in ESCC were investigated both in vitro and in vivo.
Conclusions: We found the independent ESCC survival predictors and potential therapy targets. Nevertheless, the effects of numerous low-frequency mutations need to be explored using larger sample sequencing. Overall, constructing multi-gene prognostic signatures will remain a great challenge in the future.
Keywords: Copy number variation; Esophageal squamous cell carcinoma; Prognostic analysis.
Similar articles
-
ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.Carcinogenesis. 2014 Sep;35(9):1941-50. doi: 10.1093/carcin/bgu043. Epub 2014 Feb 7. Carcinogenesis. 2014. PMID: 24510239
-
Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.Carcinogenesis. 2019 Oct 16;40(10):1198-1208. doi: 10.1093/carcin/bgz077. Carcinogenesis. 2019. PMID: 31050728
-
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284. World J Gastroenterol. 2016. PMID: 26900290 Free PMC article. Review.
-
Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.Am J Hum Genet. 2015 Apr 2;96(4):597-611. doi: 10.1016/j.ajhg.2015.02.017. Am J Hum Genet. 2015. PMID: 25839328 Free PMC article.
-
The management of localized esophageal squamous cell carcinoma: Western approach.Chin Clin Oncol. 2017 Oct;6(5):46. doi: 10.21037/cco.2017.07.07. Chin Clin Oncol. 2017. PMID: 29129086 Review.
Cited by
-
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.Oncotarget. 2017 Jul 18;8(29):46756-46768. doi: 10.18632/oncotarget.18606. Oncotarget. 2017. PMID: 28657901 Free PMC article.
-
Identification of genome-wide copy number variation-driven subtypes for the treatment and prognostic prediction of esophageal carcinoma.Heliyon. 2024 Sep 18;10(19):e38011. doi: 10.1016/j.heliyon.2024.e38011. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386821 Free PMC article.
-
Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.Aging (Albany NY). 2021 Feb 26;13(5):6999-7019. doi: 10.18632/aging.202556. Epub 2021 Feb 26. Aging (Albany NY). 2021. PMID: 33638948 Free PMC article.
-
MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma in vivo and in vitro via the MEK1-mediated ERK-MMP signaling pathway.Aging (Albany NY). 2022 Apr 25;14(8):3540-3553. doi: 10.18632/aging.204028. Epub 2022 Apr 25. Aging (Albany NY). 2022. PMID: 35468097 Free PMC article.
-
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.BMC Med Genomics. 2021 Jan 28;14(1):31. doi: 10.1186/s12920-021-00876-4. BMC Med Genomics. 2021. PMID: 33509178 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical